<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02304913</url>
  </required_header>
  <id_info>
    <org_study_id>14-5953-BO</org_study_id>
    <nct_id>NCT02304913</nct_id>
  </id_info>
  <brief_title>Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy</brief_title>
  <acronym>OralAcu</acronym>
  <official_title>Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <brief_summary>
    <textblock>
      This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to
      sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of
      dysgeusia in cancer patients undergoing chemotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Taste disorders are frequent side effects in patients undergoing chemotherapy (CTX).
      Dysguesia has prevalence rates of 16% to 1000% during CTX with sometimes also persistent
      courses. Impact of dysguesia on appetite, body weight as well as health-related quality of
      life was shown. Until now, evidence for adequate treatment options is limited to specific
      diary recommendations. Acupuncture in the treatment of side effects of chemotherapy was
      investigated for nausea and xerostomia, but not for dysguesia. Therefore, this randomized
      controlled trial aims to investigate hypoglossal acupuncture in comparison to sham
      acupuncture and standard medical treatment (dietary recommendations) in the treatment of
      dysgeusia in cancer patients undergoing chemotherapy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dysgeusia (Phantogeusia) (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dysgeusia (Parageusia, Hypogeusia, Hypergeusia) (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Xerostomia (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stomatitis (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appetite (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impairment (NRS - Numeric Rating Scale)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events (free text)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Treatment Expectancy and Credibility (TCS - Treatment Credibility Scale + BI - Blining Index)</measure>
    <time_frame>7 days</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Acupuncture</condition>
  <condition>Taste Disorders</condition>
  <condition>Dysgeusia</condition>
  <condition>Chemotherapy</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Hypoglossal acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following acupuncture points will be engraved: Jinjin (EX-HN12) and Yuye (EX-HN13).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham acupuncture</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The sham acupuncture will also carried out twice, each time after the CTX cycle. But the needle will be applied 1-1,5 cun beside the real acupuncture points in the palate using the dull side of the needle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary recommendations</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group adheres to specific dietary recommendations for dysgeusia of the German Cancer Society.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoglossal acupuncture</intervention_name>
    <arm_group_label>Hypoglossal acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham acupuncture</intervention_name>
    <arm_group_label>Sham acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary recommendations</intervention_name>
    <arm_group_label>Dietary recommendations</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Initial treatment with platinum-containing or taxane-based CTX (regardless of the the
             length of the CTX cycle)

          -  Breast cancer

          -  Phantogeusia (on average ≥4 NRS)

          -  Willingness to participate in the study and written informed consent

        Exclusion Criteria:

          -  Severe stomatitis

          -  Dysgeusia before the CTX based on neurological diseases or the ingestion of drugs with
             taste disorders as side effects

          -  Leucopenia/neutropenia

          -  Intake of anticoagulants

          -  Smoking

          -  Severe physical or mental comorbidity (due to which the patient is unable to
             participate in the study)

          -  Participation in other CAM treatments within the integrative oncology care

          -  Participation in other studies on the effectiveness of interventions for oral
             complications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Dobos, Prof., MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Internal and Integrative Medicine | Kliniken Essen-Mitte | Faculty of Medicine | University of Duisburg-Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heidemarie Haller, MSc</last_name>
    <phone>004920117425044</phone>
    <email>h.haller@kliniken-essen-mitte.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gynecology &amp; Gynecologic Oncology, Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidemarie Haller, MSc</last_name>
      <phone>004920117425044</phone>
      <email>h.haller@kliniken-essen-mitte.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Senology, St. Josef's Hospital Hilden</name>
      <address>
        <city>Hilden</city>
        <zip>40724</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aleksandra Schönthal</last_name>
      <email>sansanna2001@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>November 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2014</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Heidemarie Haller</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysgeusia</mesh_term>
    <mesh_term>Taste Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

